The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Prophylactic antibiotic therapy for chronic bronchitis
Staykova, T., Black, P., Chacko, E., & Poole, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004105 · Cited by 86
RetractedVestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1843cc · Cited by 1,032
Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD
Nishimura, K., Izumi, T., Tsukino, M., & Oga, T. (2002) · Chest · doi:10.1378/chest.121.5.1434 · Cited by 996
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.7.818 · Cited by 911
Epidemiology and costs of chronic obstructive pulmonary disease
Chapman, K. R., Mannino, D. M., Soriano, J. B., Vermeire, P. A., Buist, A. S., Thun, M. J., Connell, C., Jemal, A., Lee, T. A., Miravitlles, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024505 · Cited by 704
Self-citationO’Donnell, D. E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Physical activity in patients with COPD
Watz, H., Waschki, B., Meyer, T., & Magnussen, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00024608 · Cited by 684
Aaron, S. D., Vandemheen, K. L., Fergusson, D., Maltais, F., Bourbeau, J., Goldstein, R., Balter, M., O'Donnell, D., McIvor, A., Sharma, S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00152 · Cited by 649
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
The overlap syndrome of asthma and COPD: what are its features and how important is it?
Gibson, P. G., & Simpson, J. L. (2009) · Thorax · doi:10.1136/thx.2008.108027 · Cited by 611
Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma
Peters, S. P., Kunselman, S. J., Icitovic, N., Moore, W. C., Pascual, R., Ameredes, B. T., Boushey, H. A., Calhoun, W. J., Castro, M., Cherniack, R. M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008770 · Cited by 519
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Antó, J. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-896oc · Cited by 509
Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease
Patel, I. S., Vlahos, I., Wilkinson, T. M. A., Lloyd-Owen, S. J., Donaldson, G. C., Wilks, M., Reznek, R. H., & Wedzicha, J. A. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-648oc · Cited by 460
Han, M. K., Kazerooni, E. A., Lynch, D. A., Liu, L. X., Murray, S., Curtis, J. L., Criner, G. J., Kim, V., Bowler, R. P., Hanania, N. A., et al. (2011) · Radiology · doi:10.1148/radiol.11110173 · Cited by 453
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146306 · Cited by 453
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Brusasco, V (2005) · Thorax · doi:10.1136/thx.2005.brusascolett · Cited by 431
The clinical features of the overlap between COPD and asthma
the COPDGene Investigators, Hardin, M., Silverman, E. K., Barr, R. G., Hansel, N. N., Schroeder, J. D., Make, B. J., Crapo, J. D., & Hersh, C. P. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-127 · Cited by 428
Brusasco, V (2003) · Thorax · doi:10.1136/thorax.58.5.399 · Cited by 409
Welte, T., Miravitlles, M., Hernandez, P., Eriksson, G., Peterson, S., Polanowski, T., & Kessler, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0492oc · Cited by 408
Self-citationZheng, J.-P., Kang, J., Huang, S.-G., Chen, P., Yao, W.-Z., Yang, L., Bai, C.-X., Wang, C.-Z., Wang, C., Chen, B.-Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60869-7 · Cited by 358
Annual Change in Pulmonary Function and Clinical Phenotype in Chronic Obstructive Pulmonary Disease
Nishimura, M., Makita, H., Nagai, K., Konno, S., Nasuhara, Y., Hasegawa, M., Shimizu, K., Betsuyaku, T., Ito, Y. M., Fuke, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0992oc · Cited by 344
Properties of the COPD assessment test in a cross-sectional European study
Jones, P. W., Brusselle, G., Dal Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., Perez, T., Soler Cataluña, J. J., van der Molen, T., Adamek, L., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00177210 · Cited by 341
Self-citationvan Noord, J. A., Aumann, J.-L., Janssens, E., Smeets, J. J., Verhaert, J., Disse, B., Mueller, A., & Cornelissen, P. J. G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00140404 · Cited by 341
Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Sanchez-Toril, F., McIvor, A., Teichmann, P., Bredenbroeker, D., & Fabbri, L. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1563oc · Cited by 325
The Chronic Bronchitic Phenotype of COPD
Kim, V., Han, M. K., Vance, G. B., Make, B. J., Newell, J. D., Hokanson, J. E., Hersh, C. P., Stinson, D., Silverman, E. K., & Criner, G. J. (2011) · Chest · doi:10.1378/chest.10-2948 · Cited by 323
Kardos, P., Wencker, M., Glaab, T., & Vogelmeier, C. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-244oc · Cited by 314
Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients
Soler-Cataluña, J. J., Martínez-García, M. Á., Sánchez, L. S., Tordera, M. P., & Sánchez, P. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.12.005 · Cited by 309
Self-citationvan der Valk, P., Monninkhof, E., van der Palen, J., Zielhuis, G., & van Herwaarden, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-512oc · Cited by 298
Rennard, S. I., Calverley, P. M., Goehring, U. M., Bredenbröker, D., & Martinez, F. J. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-18 · Cited by 284
PAPI, A., ROMAGNOLI, M., BARALDO, S., BRACCIONI, F., GUZZINATI, I., SAETTA, M., CIACCIA, A., & FABBRI, L. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9910112 · Cited by 280
Nannini, L. J., Poole, P., Milan, S. J., Holmes, R., & Normansell, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub4 · Cited by 274
Grandjean, E. M., Berthet, P., Ruffmann, R., & Leuenberger, P. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88479-9 · Cited by 270
Factors Associated With Bronchiectasis in Patients With COPD
Martínez-García, M. Á., Soler-Cataluña, J. J., Donat Sanz, Y., Catalán Serra, P., Agramunt Lerma, M., Ballestín Vicente, J., & Perpiñá-Tordera, M. (2011) · Chest · doi:10.1378/chest.10-1758 · Cited by 267
Self-citationNannini, L. J., Lasserson, T. J., & Poole, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006829.pub2 · Cited by 264
Chronic mucus hypersecretion in COPD and death from pulmonary infection
Prescott, E., Lange, P., & Vestbo, J. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081333 · Cited by 260
Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC
Soler-Cataluña, J. J., Cosío, B., Izquierdo, J. L., López-Campos, J. L., Marín, J. M., Agüero, R., Baloira, A., Carrizo, S., Esteban, C., Galdiz, J. B., et al. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2011.12.009 · Cited by 237
Self-citationMucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Black, P. N., & Cates, C. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub4 · Cited by 225
Diagnóstico y tratamiento de las bronquiectasias
Vendrell, M., de Gracia, J., Olveira, C., Ángel Martínez, M., Girón, R., Máiz, L., Cantón, R., Coll, R., Escribano, A., & Solé, A. (2008) · Archivos de Bronconeumología · doi:10.1157/13128330 · Cited by 213
The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study
de Oca, M. M., Halbert, R. J., Lopez, M. V., Perez-Padilla, R., Tálamo, C., Moreno, D., Muiño, A., Jardim, J. R. B., Valdivia, G., Pertuzé, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00141611 · Cited by 198
Impact of changes in physical activity on health-related quality of life among patients with COPD
Esteban, C., Quintana, J. M., Aburto, M., Moraza, J., Egurrola, M., Pérez-Izquierdo, J., Aizpiri, S., Aguirre, U., & Capelastegui, A. (2010) · European Respiratory Journal · doi:10.1183/09031936.00021409 · Cited by 192
Clinical Phenotypes of COPD: Identification, Definition and Implications for Guidelines
Miravitlles, M., Calle, M., & Soler-Cataluña, J. J. (2012) · Archivos de Bronconeumología (English Edition) · doi:10.1016/j.arbr.2012.01.003 · Cited by 189
Self-citationthe PULSE Study group, Sethi, S., Jones, P. W., Theron, M. S., Miravitlles, M., Rubinstein, E., Wedzicha, J. A., & Wilson, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-10 · Cited by 188
Self-citationLung function impairment, COPD hospitalisations and subsequent mortality
Garcia-Aymerich, J., Serra Pons, I., Mannino, D. M., Maas, A. K., Miller, D. P., & Davis, K. J. (2011) · Thorax · doi:10.1136/thx.2010.152876 · Cited by 183
Miravitlles, M., Calle, M., & Soler-Cataluña, J. J. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2011.10.007 · Cited by 170
Self-citationGuía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC
Peces-Barba, G., Albert Barberà, J., Agustí, À., Casanova, C., Casas, A., Luis Izquierdo, J., Jardim, J., Varela, V. L., Monsó, E., Montemayor, T., et al. (2008) · Archivos de Bronconeumología · doi:10.1157/13119943 · Cited by 168
Aalbers, R., Ayres, J. G., Backer, V., Decramer, M., Lier, P. A., Magyar, P., Małolepszy, J., Ruffin, R. E., & Sybrecht, G. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00240902 · Cited by 153
Zhou, Y., Wang, X., Zeng, X.-Y., Qiu, R., Xie, J., Liu, S., Zheng, J., Zhong, N., & Ran, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00897.x · Cited by 147
Nannini, L. J., Cates, C. J., Lasserson, T. J., & Poole, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006829 · Cited by 129
Plan de calidad para el Sistema Nacional de Salud
Arguedas, M. M. (2006) · Revista Española de Podología · Cited by 125
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
Bateman, E. D., Rabe, K. F., Calverley, P. M. A., Goehring, U.-M., Brose, M., Bredenbröker, D., & Fabbri, L. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00178710 · Cited by 120
Wilt, T. J., Niewoehner, D. E., MacDonald, R. H., & Kane, R. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-9-200711060-00009 · Cited by 118
Cough and sputum production as risk factors for poor outcomes in patients with COPD
Miravitlles, M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.003 · Cited by 112
Self-citationPuhan, M. A., Bachmann, L. M., Kleijnen, J., ter Riet, G., & Kessels, A. G. H. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-2 · Cited by 108
Predictive accuracy of patient-reported exacerbation frequency in COPD
Quint, J. K., Donaldson, G. C., Hurst, J. R., Goldring, J. J. P., Seemungal, T., & Wedzicha, J. A. (2010) · European Respiratory Journal · doi:10.1183/09031936.00035909 · Cited by 85
Nadeem, N. J., Taylor, S. J., & Eldridge, S. M. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-107 · Cited by 85
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Pomares, X., Montón, C., Espasa, M., Salas, J. C., Monsó, E., & Gallego, M. (2011) · International Journal of COPD · doi:10.2147/copd.s23655 · Cited by 78
Ram, F. S., Jardin, J. R., Atallah, Á. N., Castro, A. A., Mazzini, R., Goldstein, R. S., Lacasse, Y., & Cendon, S. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.009 · Cited by 76
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., & Black, P. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub2 · Cited by 69
Appleton, S., Jones, T. E., Poole, P., Pilotto, L., Adams, R., Lasserson, T. J., Smith, B. J., & Muhammed, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001387.pub2 · Cited by 67
Targeted treatment in COPD: a multi-system approach for a multi-system disease
Anderson, D. R. (2009) · International Journal of COPD · doi:10.2147/copd.s2999 · Cited by 67
Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD
Liesker, J. J. W., Bathoorn, E., Postma, D. S., Vonk, J. M., Timens, W., & Kerstjens, H. A. M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.002 · Cited by 60
Stockley, R. A., Whitehead, P. J., & Williams, M. K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-147 · Cited by 52
A new perspective on optimal care for patients with COPD
Postma, D. S., Anzueto, A., Calverley, P. M. A., Jenkins, C. R., Make, B. J., Sciurba, F. C., Similowski, T., van der Molen, T., & Eriksson, G. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00041 · Cited by 41
Tratamiento individualizado de la EPOC: una propuesta de cambio
Miravitlles, M. (2009) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(09)72952-7 · Cited by 29
Self-citationHacia un nuevo enfoque en el tratamiento de la EPOC. La Guía Española de la EPOC (GESEPOC)
de GESEPOC, G. D. T. (2011) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2011.05.008 · Cited by 28
Long-acting ß-adrenoceptor agonists in the management of COPD: focus on indacaterol
Beeh, K. M. (2011) · International Journal of COPD · doi:10.2147/copd.s7371 · Cited by 23
Utilidad de los macrólidos como antiinflamatorios en las enfermedades respiratorias
Sevilla‐Sánchez, D., Soy, D., & Soler, N. (2009) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2009.10.008 · Cited by 23
Treatment Strategies in Chronic Obstructive Pulmonary Disease: A Proposal for Standardisation
López-Campos, J. L. (2010) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(10)70135-x · Cited by 22
Self-citationLópez-Campos, J. L. (2010) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2010.06.003 · Cited by 14
Self-citation
Research works printed but not linked: 11
- 2010, Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y Sociedad Española de Medicina de Familia (semFYC)
- Pistolesi, 2010, Phenotypes of chronic obstructive pulmonary disease, Hot Topics Respir Med, 5, 7
- Soler Cataluña, 2011, The frequent exacerbator. A new phenotype in COPD?, Hot Topics Respir Med, 6, 7
- Miravitlles, 2011, The overlap syndrome between asthma and COPD: implications for management, Hot Topics Respir Med, 16, 15
- 1962, Chronic bronchitis, asthma, and pulmonary emphysema, a statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases, Am Rev Respir Dis, 85, 762
- Van Noord, 2010, QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease, Thorax, 65, 1086, 10.1136/thx.2010.139113 · doi:10.1136/thx.2010.139113
- Vidal, 2006, Guidelines for the diagnosis and management of alpha-1-antitrypsin deficiency, Arch Bronconeumol, 42, 645, 10.1157/13095974 · doi:10.1157/13095974
- Miravitlles, 2011, Arguments in favor of inhaled corticosteroids in COPD by phenotype instead of by severity, Arch Bronconeumol, 47, 271, 10.1016/j.arbres.2011.01.016 · doi:10.1016/j.arbres.2011.01.016
- Miravitlles, 2009, Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD, Eur Respir J, 34, 1066, 10.1183/09031936.00195608 · doi:10.1183/09031936.00195608
- Adams, 2009, Evaluation of withdrawal of maintenance tiotropium in COPD, Respir Med, 103, 1415, 10.1016/j.rmed.2009.05.018 · DOI
- Schermer, 2004, Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice, Prim Care Respir J, 13, 48, 10.1016/j.pcrj.2003.11.005 · doi:10.1016/j.pcrj.2003.11.005
Cited by
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Trigueros, J. A., Cosío, B. G., Casanova, C., Antonio Riesco, J., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.03.018 · Cited by 378
Self-citationPuig-Vilanova, E., Rodriguez, D. A., Lloreta, J., Ausin, P., Pascual-Guardia, S., Broquetas, J., Roca, J., Gea, J., & Barreiro, E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.006 · Cited by 167
Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms
Kankaanranta, H., Kauppi, P., Tuomisto, L. E., & Ilmarinen, P. (2016) · Mediators of Inflammation · doi:10.1155/2016/3690628 · Cited by 122
“The coexistence of asthma and COPD or the recently characterised asthma-COPD overlap syndrome (ACOS) has been reviewed and characterized in treatment guidelines of both asthma and COPD, for example, in Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lund Disease (GOLD) reports and in…”
BackgroundBarreiro, E., & Gea, J. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316642366 · Cited by 87
Puig-Vilanova, E., Martínez-Llorens, J., Ausin, P., Roca, J., Gea, J., & Barreiro, E. (2015) · Clinical Science · doi:10.1042/cs20140428 · Cited by 84
Metadata
- Authors
- Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., López-Campos, J. L., Soriano, J. B., & Ancochea, J.
- Venue
- Archivos de Bronconeumología
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 48
- Issue
- 7
- Pages
- 247-257
- ISSN
- 0300-2896 (ISSN-L)
- OpenAlex
- W2130138851
- Cited by
- 257
- References
- 80
- FWCI
- 24.66
- Type
- journal article
- Language
- es
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.